Chloramphenicol sodium succinate
-
Chloramphenicol sodium succinate
structure -
-
CAS No:
982-57-0
-
Formula:
C15H16Cl2N2O8.Na
-
Chemical Name:
Chloramphenicol sodium succinate
-
Synonyms:
Butanedioic acid,1-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester,sodium salt (1:1);Succinic acid,α-monoester with D-threo-(-)-2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl]acetamide,monosodium salt;Butanedioic acid,mono[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester,monosodium salt,[R-(R*,R*)]-;Butanedioic acid,mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester,monosodium salt;Chloramphenicol sodium succinate;Chloramphenicol succinate sodium salt;Chloromycetin sodium succinate;Levomycetin-Nalcein;Sodium chloramphenicol 3-succinate;Solnicol;Chloramphenicol succinate sodium;Sodium chloramphenical monosuccinate;D-Chloramphenicol sodium succinate;Chloramphenicol sodium monosuccinate;Chlorocid S;Levomycetin sodium succinate;Sodium chloramphenicol succinate;Betamicetin;Mychel-S;Nalecin;Nevimycin;Clorofenicina;Cloromoin;Chloramphenicol sodium hemisuccinate;Cidocetine;Protophenicol;Chloramphenicol monosuccinate sodium salt;39095-30-2;72792-80-4
- Categories:
-
CAS No:
Description
Chloramphenicol succinate sodium is a prodrug of Chloramphenicol, with Haemotoxicity. Chloramphenicol succinate is a competitive substrate and inhibitor of succinate dehydrogenase (SDH) that is the possible reason for its toxicity[1][2][3].
Chloramphenicol sodium succinate is a white powder. (NTP, 1992)
Chloramphenicol sodium succinate is a white powder. (NTP, 1992)|Chloramphenicol Sodium Succinate is the sodium succinate salt form of chloramphenicol, a nitrobenzene derivate and broad-spectrum antibiotic with antibacterial activity. Chloramphenicol sodium succinate reversibly binds to the 50S subunit of bacterial ribosomes, thereby interfering with peptidyl transferase activity in the elongation process of protein synthesis. As a result, this agent prevents bacterial cell growth.
Chloramphenicol sodium succinate Basic Attributes
445.19
444.010315
213-568-1
872109HX6B
DTXSID2024747
C47972
Characteristics
161.58000
0.90410
Chloramphenicol sodium succinate is a white powder. (NTP, 1992)
716.3ºC at 760mmHg
387ºC
H2O: soluble 50mg/mL
Celiac-rat LD50: 1400 mg/kg; Intravenous-Mouse LD50: 1530 mg/kg
Thermal decomposition releases toxic nitrogen oxides, chlorides, sodium oxide fumes
Freely soluble in water.
Alcohols and Polyols
Safety Information
NONH for all modes of transport
3
40
22-36
AB6905000
Xn
The warehouse is low-temperature, ventilated and dry
P280
H351
Flash point data for this chemical are not available, but it is probably combustible. (NTP, 1992)
|Warning|H351 (95%): Suspected of causing cancer [Warning Carcinogenicity]|P201, P202, P281, P308+P313, P405, and P501|Aggregated GHS information provided by 40 companies from 3 notifications to the ECHA C&L Inventory.
Fires involving this material may be controlled using a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. STORAGE PRECAUTIONS: You should store this material in a refrigerator. (NTP, 1992)
RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)
Drug Information
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
SYMPTOMS: Symptoms of exposure to this compound include bone marrow depression, serious and fatal blood disorders, nausea, vomiting, glossitis and stomatitis, diarrhea, enterocolitis, headache, mild depression, mental confusion, delirium, optic and peripheral neuritis, fever, macular and vesicular rashes, angioedema, urticaria, anaphylaxis, Herxheimer reactions, and "Gray Syndrome". ACUTE/CHRONIC HAZARDS: This chemical may cause skin irritation. When heated to decomposition it emits very toxic fumes. (NTP, 1992)
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment. INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing. INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)
chloramphenicol hemisuccinate
Chloramphenicol sodium succinate Use and Manufacturing
Chloramphenicol succinate sodium is the salt prepared from chloramphenicol succinate using the free carboxylic acid of the succinate which ionises and readily forms in weak sodium hydroxide solutions. The sodium salt is the preferred formulation for pharmaceutical applications, providing a more readily soluble product. Chloramphenicol succinate is significantly less active than chloramphenicol but acts as a prodrug, forming chloramphenicol in the presence of succinate dehydrogenase.
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:445.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:9
Exact Mass:444.0103151
Monoisotopic Mass:444.0103151
Topological Polar Surface Area:162
Heavy Atom Count:28
Complexity:541
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Chloramphenicol sodium succinate
-
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
3 YRS
Business licensed Certified factoryManufactory Supplier of Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed Additive
Latest News on Chloramphenicol sodium succinate
- The world's first uniform international safety standard for plastics and rubber
- The nation's first group standard for meltblown cloth for masks is released
- Several compulsory national standards have been issued
- Japan has seized the right to formulate international standards
- Henan Efforts to Improve the Standardized Management Level of Food Production
Learn More Other Chemicals
-
Glycine, N,N-bis(carboxymethyl)-, calcium sodium salt (1:1:1)
60034-45-9
-
Hypophosphoric acid, sodium salt (1:2)
7782-95-8
-
2,6-Naphthalenedisulfonic acid, 4-hydroxy-3-[2-(2-methoxy-5-methylphenyl)diazenyl]-, sodium salt (1:2)
5864-85-7
-
Benzenesulfonic acid, 4-[2-(4-hydroxyphenyl)diazenyl]-, sodium salt (1:1) Formula
2623-36-1
-
2-Naphthalenesulfonic acid, 6-amino-5-[2-[4-[(2-bromo-1-oxo-2-propen-1-yl)amino]-2-[(4-methyl-3-sulfophenyl)sulfonyl]phenyl]diazenyl]-, sodium salt (1:2) Formula
85187-33-3
-
4-Piperidinecarboxylic acid, 4-(phenylamino)-1-(phenylmethyl)-, sodium salt (1:1) Formula
61085-47-0
-
Amines, N-C8-22-alkyltrimethylenedi-, acrylated, sodium salts Structure
97659-50-2
-
Zirconate (ZrO32-), sodium (1:2) Structure
12201-48-8
-
What is 2',3'-DIDEOXYADENOSINE-5'-O-(1-THIOTRIPHOSPHATE) SODIUM SALT
154902-26-8
-
What is 1,3-Propanedisulfonic acid, 1,1′-[sulfonylbis(4,1-phenyleneimino)]bis[3-phenyl-, sodium salt (1:4)
133-65-3
Chloramphenicol sodium succinate
SDSRequest for Quotation